title: Nontraditional management of basal cell carcinoma.
abstract: This review discusses nontraditional modalities available for the treatment of basal cell carcinoma along with the existing evidence to support their respective uses in varying clinical situations. By definition, these modalities are nonsurgical, and in many cases, are not approved by the US Food and Drug Administration as treatments for basal cell carcinoma, including topical chemotherapies, photodynamic therapy, oral therapies, and complementary therapies. Nonetheless, as the population of patients with skin cancer increases at epidemic proportions, many of these modalities are, and will become, increasingly relevant in the dermatologist's armamentarium.
authors: Department of Dermatology, Tufts Medical Center, Boston, MA, USA. nbotto@tuftsmedicalcenter.org
authors: Nina
authors: N
authors: Botto
authors: Gary
authors: G
authors: Rogers
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D002280:Basal Cell Carcinoma / Q000453:epidemiology / Q000473:pathology / Q000628:therapy*; D000529:Complementary Therapies / Q000379:methods; D006801:Humans; D010778:Photochemotherapy / Q000379:methods; D012878:Skin Neoplasms / Q000453:epidemiology / Q000473:pathology / Q000628:therapy*
chemical_list: D000970:Antineoplastic Agents